![Thomas Stratford](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Stratford
Direttore/Membro del Consiglio presso Kyowa Kirin International Plc
Posizioni attive di Thomas Stratford
Società | Posizione | Inizio | Fine |
---|---|---|---|
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | 07/09/2011 | - |
Storia della carriera di Thomas Stratford
Precedenti posizioni note di Thomas Stratford
Società | Posizione | Inizio | Fine |
---|---|---|---|
GSK PLC | Corporate Officer/Principal | - | - |
Formazione di Thomas Stratford
King's College London | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 4 |
Posizioni
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
GSK PLC | Health Technology |
Aziende private | 1 |
---|---|
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Thomas Stratford
- Esperienza